Best Abstracts Session
S4
.1 Restoring glucose homeostasis with stomach-derived human insulin-secreting organoidsS4
.2 Identification of beta cell differentiation-prone iPSC clonesS4
.3 AKT inhibitor AT7867 potentiates pancreatic progenitor differentiation of human pluripotent stem cellsS4
.4 Nutrient control of insulin secretion in stem cell-derived isletsS4
.5 Synthetic hydrogels for islet/SC vascularization, engraftment, and immune acceptanceS4
.6 Allogeneic pancreatic islets transplanted to a bioengineered omentum achieves euglycemic control in a diabetic NHP modelS4
.7 Complete suspension culture biomanufacturing of human pluripotent stem cell-derived islets for diabetes cell therapyS4
.8 Vascularization of beta cell mass in device-encapsulated hPSC-derived pancreatic endoderm implants in subcutis of nude ratsS4
.9 Immuno-privileged hydrogels protect functionality of islets transplanted into immunocompetent diabetic animals without immunosuppressionS4
.10 Pre-vascularized bioartificial pancreas device development using 3D printingS4
.11 Transplanted pluripotent stem cell-derived islets engraft superior to human isletsS4
.12 Deciphering the hematopoietic pancreatic niche during human fetal developmentS4
.13 Manufacturing of optimized human islet-like clusters (ILCs) from iPSCs and functional testing of an ILC + Cell PouchTM combination in vivo